| Literature DB >> 24868276 |
Ashish Motewar1, Mandar Tilak1, Deepak Patil1, Nikhil Bhamare1, Laxmikant Bhople1.
Abstract
INTRODUCTION: Duodenal perforation is one of the common pathologies in patients presenting in emergency with acute abdominal pain in an emergency ward and requires prompt surgery as life saving and curative intervention. The present study was conducted to determine whether the minimal access approach by laparoscopy was equally feasible as the open method. AIM: To compare laparoscopic vs. open management duodenal perforation in all aspects. INCLUSION CRITERIA: patients presenting to the emergency ward with acute pain in the abdomen with clinical signs of peritonitis and air under the diaphragm on X-ray abdomen standing were selected. Exclusion criteria were: patient age < 15 years and > 70 years, presentation > 2 days, shock with systolic blood pressure < 90 mm Hg which did not improve after hydration with 2000 ml of Ringer lactate solution, respiratory distress, history of cardiac disorder or respiratory disorders such as ischemic heart disease, arrhythmias, chronic obstructive pulmonary disease or asthma, bleeding and clotting disorders, pregnancy in females, previous upper abdominal surgery, and intra-operatively patients having perforation other than duodenal perforation. After excluding patients fitting the above criteria, two groups - test and control - were formed.Entities:
Keywords: duodenal perforation; laparoscopic vs. open; management
Year: 2013 PMID: 24868276 PMCID: PMC4027821 DOI: 10.5114/pg.2013.38735
Source DB: PubMed Journal: Prz Gastroenterol ISSN: 1895-5770
Age and sex characteristics
| Parameter | Male | Female | Total |
|---|---|---|---|
| Test | 45 (64.28) | 25 (35.72) | 70 |
| Control | 42 (60) | 28 (40) | 70 |
Significant history
| Parameter | Test group | Control group |
|---|---|---|
| Smoking | 37 | 38 |
| Suggestive of acid peptic disease | 14 | 12 |
Intra-operative observations
| Observations | Test group | Percentage | Control group | Percentage |
|---|---|---|---|---|
| Average intra-op time [min] | 50 | NA | 48 | NA |
| Uncontrolled bleeding | 0 | 0 | NA | NA |
| Iatrogenic perforation | 0 | 0 | 0 | 0 |
| Liver injury | 0 | 0 | 5 | 7.14 |
| Conversion to laparotomy | 3 | 4.28 | NA | NA |
NA – not applicable
Post-operative observations and late post-operative complications
| No. | Observation | Test | Percentage | Control | Percentage | Values of |
|---|---|---|---|---|---|---|
| 1 | Average time since start of oral feeding | 3 days | NA | 5 days | NA | NA |
| 2 | Average time of discharge (total hospital stay) | 6.5 days | NA | 9.5 days | NA | NA |
| 3 | Respiratory complication: atelectasis, pneumonia, need for ventilatory support | 3 | 4.28 | 14 | 20 | 0.001 |
| 4 | Intra-abdominal abscess | 0 | 0 | 4 | 5.71 | 0.0394 |
| 5 | Wound infection/wound dehiscence | 3 (no dehiscence) | 4.28 | 18 (4 dehiscence) | 25.71 | < 0.0001 |
| 6 | Post-operative leakage of sutured perforation | 2 | 2.85 | 1 | 1.42 | 0.4731 |
| 7 | Mortality | 3 | 6 | 1.641 | 0.2002 | |
| 8 | Post-operative gastric outlet obstruction on long-term follow-up (3 years) | 0 | 0 | 3 | 4.28 | 0.0767 |
| 9 | Post-operative adhesion obstruction on follow-up (3 years) | 0 | 0 | 15 | 20.14 | < 0.0001 |
Various studies
| Study | No. of patients | Mean operative time [min] | Conversion to open surgery | Mean hospital stay | Morbidity | Mortality | Mean time for laparotomy | Mean hospital stay [days] | Morbidity in laparotomy patients | Mortality in laparotomy patients |
|---|---|---|---|---|---|---|---|---|---|---|
| Palanivelu | 120 | 46 | 0 | 5.5 | 9 | 0 | NA | NA | NA | NA |
| Druart | 100 | 80 | 8 | 9.3 | 9 | 5 | NA | NA | NA | NA |
| Lau | 24 | 112 | 7 | 5 | 5 | 0 | NA | NA | NA | NA |
| Schirru | 39 | 77 | 5 | 9 | 5 | 4 | NA | NA | NA | NA |
| Matsuda | 14 | 135 | 3 | 17 | 1 | 0 | NA | NA | NA | NA |
| Abid | 84 | 95 | 12 | – | 15.4 | – | NA | NA | NA | NA |
| Vaidya | 31 | 105 | 2 | 5.5 | 9 | 0 | NA | NA | NA | NA |
| Shiraz | 27/27 | 55.74 | 0 | 4.67 | 8 | 0 | 47.41 | 6.52 | 22 | 0 |
| Mehendale | 34/33 | 50 | 4 | 6 | – | 0 | 55 | 9 | – | 0 |
| LAMA trial [ | 52/50 | 75 | 4 | 6.5 | 10 | 2 | 50 | 8.0 | 20 | 4 |
| Our study | 70/70 | 88 | 6 | 6.5 | 7 | 0 | 48 | 9.5 | 17 | 0 |